Candel Therapeutics (CADL) Return on Sales [ROS] (2020 - 2022)
Candel Therapeutics (CADL) recorded Return on Sales [ROS] of -26132.26% in Q4 2022, down 1164.52 percentage points from -24967.74% a year earlier but up 2516.13 percentage points from the prior quarter.
Powered by 
Analysis
Candel Therapeutics (CADL) Return on Sales [ROS] (2020 - 2022) Analysis & Trends
For FY2022, Candel Therapeutics reported Return on Sales [ROS] of -27777.60%, down 7196.80 percentage points from FY2021.
- Across earlier years, Return on Sales [ROS] came in at -20580.80% in FY2021 (-9532.80 pp) and -11048.00% in FY2020.
- Quarterly Return on Sales [ROS] has ranged from -28987.10% in Q1 2022 to -8448.39% in Q2 2020 over the past five years.
- On a year-over-year basis, Return on Sales [ROS] has declined for seven consecutive quarters, with an average year-over-year change of -8558.06 percentage points over the last seven quarters.
- Per Business Quant, the preceding three quarters came in at -28648.39% (Q3 2022), -28235.48% (Q2 2022) and -28987.10% (Q1 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Candel Therapeutics | 774.88 Mn | 774.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -26,132.26% |
| Sep 30, 2022 | -28,648.39% |
| Jun 30, 2022 | -28,235.48% |
| Mar 31, 2022 | -28,987.10% |
| Dec 31, 2021 | -24,967.74% |
| Sep 30, 2021 | -25,900.00% |
| Jun 30, 2021 | -17,100.00% |
| Mar 31, 2021 | -15,022.58% |
| Dec 31, 2020 | -19,758.06% |
| Sep 30, 2020 | -8,867.74% |
| Jun 30, 2020 | -8,448.39% |
API Access
Candel Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CADL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "CADL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CADL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();